SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:kth-331842"
 

Search: id:"swepub:oai:DiVA.org:kth-331842" > Biliverdin Reductas...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Chemaly, MelodyKarolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden. (author)

Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • MDPI AG,2023
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:kth-331842
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-331842URI
  • https://doi.org/10.3390/biom13060882DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:237371462URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:152955134URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • QC 20230714
  • Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Biliverdin reductase B (BLVRB) is enriched in plasma and plaques from patients with symptomatic carotid atherosclerosis and functionally associated with IPH. Objective: We explored the biomarker potential of plasma BLVRB through (1) its correlation with IPH in carotid plaques assessed by magnetic resonance imaging (MRI), and with recurrent ischemic stroke, and (2) its use for monitoring pharmacotherapy targeting IPH in a preclinical setting. Methods: Plasma BLVRB levels were measured in patients with symptomatic carotid atherosclerosis from the PARISK study (n = 177, 5 year follow-up) with and without IPH as indicated by MRI. Plasma BLVRB levels were also measured in a mouse vein graft model of IPH at baseline and following antiangiogenic therapy targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Results: Plasma BLVRB levels were significantly higher in patients with IPH (737.32 & PLUSMN; 693.21 vs. 520.94 & PLUSMN; 499.43 mean fluorescent intensity (MFI), p = 0.033), but had no association with baseline clinical and biological parameters. Plasma BLVRB levels were also significantly higher in patients who developed recurrent ischemic stroke (1099.34 & PLUSMN; 928.49 vs. 582.07 & PLUSMN; 545.34 MFI, HR = 1.600, CI [1.092-2.344]; p = 0.016). Plasma BLVRB levels were significantly reduced following prevention of IPH by anti-VEGFR-2 therapy in mouse vein grafts (1189 & PLUSMN; 258.73 vs. 1752 & PLUSMN; 366.84 MFI; p = 0.004). Conclusions: Plasma BLVRB was associated with IPH and increased risk of recurrent ischemic stroke in patients with symptomatic low- to moderate-grade carotid stenosis, indicating the capacity to monitor the efficacy of IPH-preventive pharmacotherapy in an animal model. Together, these results suggest the utility of plasma BLVRB as a biomarker for atherosclerotic plaque instability.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Marlevi, DavidKarolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.;MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA. (author)
  • Iglesias, Maria JesusKTH,Science for Life Laboratory, SciLifeLab,Cellulär och klinisk proteomik(Swepub:kth)u1b212k2 (author)
  • Lengquist, MarietteKarolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden. (author)
  • Kronqvist, MalinKarolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden. (author)
  • Bos, DanielErasmus MC, Univ Med Ctr Rotterdam, Dept Radiol & Nucl Med, NL-3015 GD Rotterdam, Netherlands.;Erasmus MC, Univ Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands. (author)
  • van Dam-Nolen, Dianne H. K.Erasmus MC, Univ Med Ctr Rotterdam, Dept Radiol & Nucl Med, NL-3015 GD Rotterdam, Netherlands. (author)
  • van der Kolk, AnjaRadboud Univ Nijmegen, Dept Med Imaging, Med Ctr, NL-6500 HB Nijmegen, Netherlands.;Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands. (author)
  • Hendrikse, JeroenUniv Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands. (author)
  • Kassem, MohamedMaastricht Univ, CARIM Sch Cardiovasc Dis, Dept Radiol & Nucl Med, Med Ctr, NL-6229 ER Maastricht, Netherlands. (author)
  • Matic, LjubicaKarolinska Institutet (author)
  • Odeberg, Jacob,Professor,1963-KTH,Science for Life Laboratory, SciLifeLab,Cellulär och klinisk proteomik,Karolinska Univ Hosp, Dept Hematol, S-14152 Huddinge, Stockholm, Sweden.;UiT The Arctic Univ Norway, Dept Clin Med, N-9019 Tromso, Norway.(Swepub:kth)u1e4yljo (author)
  • de Vries, Margreet R.Leiden Univ, Dept Surg, Einthoven Lab, Med Ctr, NL-2333 ZA Leiden, Netherlands. (author)
  • Kooi, M. ElineMaastricht Univ, CARIM Sch Cardiovasc Dis, Dept Radiol & Nucl Med, Med Ctr, NL-6229 ER Maastricht, Netherlands. (author)
  • Hedin, UlfKarolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.;Karolinska Univ Hosp, Dept Vasc Surg, S-17176 Stockholm, Sweden. (author)
  • Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden.;MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA. (creator_code:org_t)

Related titles

  • In:Biomolecules: MDPI AG13:62218-273X

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view